loader

otcqb:bctxf

LATEST ARTICLES
OTCQB:BCTXF

BriaCell Pioneering Immunotherapy For Advanced Breast Cancer Treatment

OTCQB:BCTXF

BriaCell’s Immunotherapy Technology Featured in The Financial Post

OTCQB:BCTXF

Bondarenko Acquires 14.48% Beneficial Ownership of BriaCell Therapeutics Corp.

OTCQB:BCTXF

BriaCell Approves New Board of Directors and Chairman at Annual and Special Meeting of Shareholders

OTCQB:BCTXF

BriaCell Therapeutics: Process Development Critical to Drug Design Process

OTCQB:BCTXF

BriaCell Announces Publication at American Society of Clinical Oncology (ASCO) Meeting and Presentation at Precision Breast Cancer Summit in Boston

OTCQB:BCTXF

Successful BioPharma Startups Focus on the Science

OTCQB:BCTXF

BriaCell’s Lead Candidate Combined With KEYTRUDA®: Strong Evidence of Rapid Additive or Synergistic Anti-Tumor Activity

OTCQB:BCTXF

BriaCell Announces Clinical Trial Collaboration Agreement with Incyte

OTCQB:BCTXF

BriaCell Announces Closing of Upsized & Oversubscribed Non-Brokered Private Placement of $2.97 Million

OTCQB:BCTXF

BriaCell to Announce Early Efficacy Data of Lead Candidate in Combination with KEYTRUDA® at AACR Annual Meeting

OTCQB:BCTXF

BriaCell Closes First Tranche of Previously Announced Non-Brokered Private Placement

Latest News

More News

Outlook Reports

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES